Avian influenza overview December 2024–March 2025
EFSA Journal · 2025-04 · 23 (4)
DOI: 10.2903/j.efsa.2025.9352 ↗Kurz gefasst
Fachartikel in der Zeitschrift EFSA Journal, 2025-04. Verfasst von European Food Safety Authority und 15 weiteren Autor:innen. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Between 7 December 2024 and 7 March 2025, 743 highly pathogenic avian influenza (HPAI) A(H5) virus detections were reported in domestic (239) and wild (504) birds across 31 countries in Europe. HPAI A(H5N1) virus detections were predominant and mainly located in central, western and south‐eastern Europe. Most HPAI A(H5) virus detections in wild birds concerned waterfowl, particularly mute swans, barnacle geese and greylag geese. Limited secondary spread was observed among the poultry outbreaks, and outdoor poultry access remained an important risk factor at the interface between wild and domestic birds. HPAI A(H5N5) outbreaks occurred only in wild birds and were increasingly reported in waterfowl. For the first time since spring 2024, several HPAI virus detections were reported in domestic cats and wild carnivores in Europe. In the United States of America (USA), the number of dairy cattle farms reportedly affected rose to almost 1000 in 17 States, and a different HPAI A(H5N1) virus genotype (D1.1) was reported in this species. Between 12 December 2024 and 7 March 2025, 22 new cases of avian influenza virus infection in humans were reported in the USA (12 A(H5) cases), Cambodia (two A(H5N1) cases), United Kingdom (one A(H5N1) case), and China (six A(H9N2) cases and one A(H10N3) case). Most of the A(H5) human cases (93%, n = 14/15) had reported exposure to poultry or dairy cattle prior to avian influenza virus detection or onset of illness. Considering the widespread circulation of avian influenza viruses in animal populations, human infections with avian influenza viruses remain infrequent. No evidence of human‐to‐human transmission has been documented during the reporting period. The risk of infection with the avian A(H5) influenza viruses of clade 2.3.4.4b currently circulating in Europe remains low for the general public in the European Union/European Economic Area (EU/EEA). The risk of infection remains low‐to‐moderate for those occupationally or otherwise exposed to infected animals or contaminated environments.
Schlagwörter
Stichwörter der Autor:innen
Zitieren
APA
European Food Safety Authority, European Centre for Disease Prevention and Control, European Union Reference Laboratory for Avian Influenza, Alexakis, L., Buczkowski, H., Ducatez, M., Fusaro, A., Gonzales, J. L., Kuiken, T., Ståhl, K., Staubach, C., Svartström, O., Terregino, C., Willgert, K., Melo, M., & Kohnle, L. (2025). Avian influenza overview December 2024–March 2025. EFSA Journal, 23(4). https://doi.org/10.2903/j.efsa.2025.9352
Vancouver
European Food Safety Authority, European Centre for Disease Prevention and Control, European Union Reference Laboratory for Avian Influenza, Alexakis L, Buczkowski H, Ducatez M, et al. Avian influenza overview December 2024–March 2025. EFSA Journal. 2025;23(4). doi:10.2903/j.efsa.2025.9352
BibTeX
@article{EuropeanFoodSafetyAuthority2025,
author = {European Food Safety Authority, European Food Safety Authority and European Centre for Disease Prevention and Control, European Centre for Disease Prevention and Control and European Union Reference Laboratory for Avian Influenza, European Union Reference Laboratory for Avian Influenza and Alexakis, Leonidas and Buczkowski, Hubert and Ducatez, Mariette and Fusaro, Alice and Gonzales, Jose L and Kuiken, Thijs and Ståhl, Karl and Staubach, Christoph and Svartström, Olov and Terregino, Calogero and Willgert, Katriina and Melo, Miguel and Kohnle, Lisa},
title = {Avian influenza overview December 2024–March 2025},
journal = {EFSA Journal},
year = {2025},
volume = {23},
number = {4},
doi = {10.2903/j.efsa.2025.9352}
}
EUVIMED